Related Experiment Video
Updated: May 14, 2026
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Update on cardiovascular disease prevention in women
1College of Nursing, State University of New York (SUNY) Downstate Medical Center, Brooklyn, NY, USA. meriam.caboral@downstate.edu
Insights
Cardiovascular disease (CVD) remains the leading cause of death for women. Updated guidelines emphasize effective interventions for women
Area of Science:
- Cardiology
- Women's Health
- Preventive Medicine
Background:
- Cardiovascular disease (CVD) is the leading cause of death in US women, surpassing cancer and other major diseases.
- Significant gaps exist in women's awareness regarding CVD risks, effective prevention strategies, and recognition of heart attack symptoms.
- Misconceptions about CVD in women, evolving data, and sex-specific differences in presentation and treatment necessitated updated guidelines.
Purpose of the Study:
- To explain the shift in emphasis in the American Heart Association (AHA) guidelines for preventing CVD in women.
- To highlight key interventions deemed "effective" for women, moving beyond solely "evidence-based" recommendations.
- To address persistent misunderstandings and knowledge gaps concerning CVD in the female population.
Main Methods:
- Review and update of the 2007 American Heart Association (AHA) guidelines for preventing CVD in women.
- Incorporation of new epidemiologic data and increased awareness of sex differences in CVD.
- Emphasis on interventions with established efficacy in women.
Main Results:
- The updated guidelines stress interventions that are "effective" in women, acknowledging sex-specific nuances in CVD.
- A greater focus is placed on educating women, particularly high-risk groups like black and Hispanic women, about CVD.
- The guidelines address the need for improved public awareness regarding heart attack symptoms and the importance of calling 9-1-1.
Conclusions:
- Updated AHA guidelines provide a refined approach to preventing cardiovascular disease in women.
- Effective, evidence-based strategies tailored to women are crucial for reducing CVD mortality.
- Enhanced public and provider education is essential to combat misconceptions and improve outcomes for women's cardiovascular health.
Overview:
In 2008, more women in the United States died from cardiovascular disease (CVD) than from all forms of cancer, chronic lower respiratory disease, and Alzheimer's disease combined. One in three deaths in women was from CVD. While many women have come to recognize CVD as the leading cause of death in women, more education is needed to convey this message to others, especially high-risk groups like black and Hispanic women. In addition, recent American Heart Association (AHA) surveys have shown that a majority of women believe they can reduce their risk of heart disease through therapies with no established benefit (such as multivitamins and antioxidants, or aspirin in young women), just over half of women said they would call 9-1-1 if experiencing symptoms of heart attack, and few respondents were aware of atypical symptoms of heart attack.Persistent misunderstandings about CVD in women; new epidemiologic data; and increased awareness of sex differences in the way CVD presents, is evaluated, and responds to treatment prompted the AHA to update its 2007 guidelines for preventing CVD in women, stressing interventions described as "effective" in women, not only "evidence based." This article explains the shift in emphasis and reports on the highlights of the updated guidelines.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
01:26Atherosclerosis III: Management
01:27Coronary Artery Disease V: Interprofessional Care
01:21Rheumatic Heart Disease III: Medical Management
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...